NEKTAR THERAPEUTICS shareholders Q3 2023

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.

NEKTAR THERAPEUTICS shareholders Q3 2023
NameSharesValueWeighting ↓
FMR LLC 76,635$45,6440.00%
DIMENSIONAL FUND ADVISORS LP 587,989$350,3380.00%
FRANKLIN RESOURCES INC 34,781$20,7160.00%
Parallel Advisors, LLC 15,820$9,4220.00%
BANK OF AMERICA CORP /DE/ 246,800$146,8460.00%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 61,886$370.00%
FIRST MANHATTAN CO. LLC. 500$2970.00%
Russell Investments Group, Ltd. 158,680$94,5090.00%
WELLS FARGO & COMPANY/MN 5,177$3,0840.00%
NORTHERN TRUST CORP 359,925$214,3720.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
VICTORY CAPITAL MANAGEMENT INC 20,475$12,1950.00%
GEODE CAPITAL MANAGEMENT, LLC 1,955,356$1,164,9050.00%
VANGUARD GROUP INC 12,061,147$7,183,6190.00%
FARMERS & MERCHANTS INVESTMENTS INC 113$670.00%
MILLENNIUM MANAGEMENT LLC 1,190,563$709,0990.00%
ROYAL BANK OF CANADA 100$00.00%
HARBOUR INVESTMENTS, INC. 155$920.00%
AMERIPRISE FINANCIAL INC 488,400$290,8910.00%
MERCER GLOBAL ADVISORS INC /ADV 17,054$100.00%
External links

This page lists NEKTAR THERAPEUTICS's shareholders in Q3 2023. To view NEKTAR THERAPEUTICS's shareholder history, click here.